• Lancet · Apr 2020

    Case Reports

    Treating hypoparathyroidism with recombinant human parathyroid hormone (1-34): long-term safety concerns.

    • Cécile Goujard, Sylvie Salenave, Karine Briot, Philippe Chanson, Gilles Grimon, and Peter Kamenický.
    • AP-HP, Hôpital Bicêtre, Service de Médecine Interne, Le Kremlin Bicêtre, France; Université Paris-Saclay, Le Kremlin Bicêtre, France.
    • Lancet. 2020 Apr 18; 395 (10232): 1304.

    no abstract available

      Pubmed     Full text   Copy Citation     Plaintext  

      Add institutional full text...

    Notes

     
    Knowledge, pearl, summary or comment to share?
    300 characters remaining
    help        

    hide…

What will the 'Medical Journal of You' look like?

Start your free 21 day trial now.

We guarantee your privacy. Your email address will not be shared.